XTL Biopharmaceuticals Ltd (XTLB) stock
XTLBNasdaqPharmaceutical Preparations
$1.60−0.04 (-2.44%)
Close on Nov 13, 2026Market cap $15.14MP/E –Yield –
XTL Biopharmaceuticals price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
XTL Biopharmaceuticals's price to sales ratio was 64.0× on Feb 27, 2026.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Feb 27, 2026 | 64.0× | +18.7 |
| 2025 | Dec 31, 2025 | 45.3× | – |
See a number that looks wrong?